Genetically, although the somatic mutations of TP53 were rare in primary NBs at diagnosis, a germline missense variant in TP53 was identified as a candidate pathogenic mutation associated with HR-NBs [25], suggesting the important role of P53 signaling pathway in UHR-NB subtype. The gene discussed is TP53; the disease is neuroblastoma.